Jefferies Group's IDXX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 20,465 shares of IDEXX Laboratories, Inc. (IDXX) worth $13.07 M, representing 0.06% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in IDXX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 16,915 shares. Largest reduction occurred in Q1 2025, reducing 7,067 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +5,700 | New Buy | 5,700 | $407.96 |
| Q1 2023 | +138 | Add 2.42% | 5,838 | $500.08 |
| Q2 2023 | -4,201 | Reduce 71.96% | 1,637 | $502.23 |
| Q3 2023 | +1,381 | Add 84.36% | 3,018 | $437.27 |
| Q4 2023 | +16,915 | Add 560.47% | 19,933 | $555.05 |
| Q1 2024 | -6,793 | Reduce 34.08% | 13,140 | $539.93 |
| Q2 2024 | -1,880 | Reduce 14.31% | 11,260 | $487.20 |
| Q3 2024 | +635 | Add 5.64% | 11,895 | $505.22 |
| Q4 2024 | +14,711 | Add 123.67% | 26,606 | $413.44 |
| Q1 2025 | -7,067 | Reduce 26.56% | 19,539 | $419.95 |
| Q2 2025 | +2,099 | Add 10.74% | 21,638 | $536.34 |
| Q3 2025 | -1,173 | Reduce 5.42% | 20,465 | $638.89 |
Jefferies Group's IDEXX Laboratories Investment FAQs
Jefferies Group first purchased IDEXX Laboratories, Inc. (IDXX) in Q4 2022, acquiring 5,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held IDEXX Laboratories, Inc. (IDXX) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q4 2023, adding 19,933 shares worth $11.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 20,465 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $13.07 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.06% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in IDEXX Laboratories, Inc. (IDXX) was 26,606 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.